PHGDH and cancer: Studies have shown that lower PHGDH levels are linked to increased metastatic potential, as the downregulation of de novo serine biosynthesis may enhance the invasiveness of cancer cells by promoting reliance on exogenous serine and other metabolic adaptations (Geeraerts et al, 2021; Labuschagne et al, 2014).